Page last updated: 2024-11-05

dithionitrobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dithionitrobenzoic Acid: A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dithionitrobenzoic acid : An organic disulfide that results from the formal oxidative dimerisation of 2-nitro-5-thiobenzoic acid. An indicator used to quantify the number or concentration of thiol groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6254
CHEMBL ID395814
CHEBI ID86228
SCHEMBL ID26775
MeSH IDM0006618

Synonyms (64)

Synonym
5-(3-carboxy-4-nitro-phenyl)disulfanyl-2-nitrobenzoic acid
5,5-dithiobis(2-nitrobenzoic acid)
69-78-3
dithiobisnitrobenzoic acid
5-[(3-carboxy-4-nitro-phenyl)disulfanyl]-2-nitro-benzoic acid
ellmans reagent
5,5'-dithiobis(2-nitrobenzoic acid)
dtnb
inchi=1/c14h8n2o8s2/c17-13(18)9-5-7(1-3-11(9)15(21)22)25-26-8-2-4-12(16(23)24)10(6-8)14(19)20/h1-6h,(h,17,18)(h,19,20
3,3'-dithiobis(6-nitrobenzoic acid)
einecs 200-714-4
benzoic acid, 3,3'-dithiobis(6-nitro-
2,2'-dinitro-5,5'-dithiodibenzoesaeure [german]
dithionitrobenzoic acid
3,3'-dithiobis(6-nitrobenzoic) acid
2,2'-dinitro-5,5'-dithiodibenzoic acid
5,5'-dithiobis(2-nitrobenzoic acid), bioreagent, >=98%, suitable for determination of sulfhydryl groups
5,5'-dithiobis(2-nitrobenzoic acid), reagentplus(r), 99%
ellman reagent
ellman's reagent
D-8000
5,5'-dithio-bis(2-nitrobenzoic acid)
5, 5'-dithiobis-(2-nitrobenzoic acid)
bis(3-carboxy-4-nitrophenyl) disulfide
D0944
CHEMBL395814 ,
chebi:86228 ,
3-carboxy-4-nitrophenyl disulfide
5-[(3-carboxy-4-nitrophenyl)disulfanyl]-2-nitrobenzoic acid
AKOS005266765
bdbm50365395
unii-9bzq3u62jx
2,2'-dinitro-5,5'-dithiodibenzoesaeure
9bzq3u62jx ,
6,6'-dinitro-3,3'-dithiodibenzoic acid
S2764
ba-2767
ellman's reagent [mi]
benzoic acid, 3,3'-dithiobis[6-nitro-
HY-15915
SCHEMBL26775
5,5'-dithio-bis-(2-nitrobenzoic acid)
5,5'-dithiobis-(2-nitrobenzoic acid)
DTXSID5058779
5,5'-disulfanediylbis(2-nitrobenzoic acid)
3,3'-disulfanediylbis(6-nitrobenzoic acid)
5,5'-dithiobis[2-nitrobenzoic acid]
5,5-dithiobis(2-nitrobenzoicacid)
mfcd00007140
GS-6886
5,5'-dithiobis(2-nitrobenzoic acid), vetec(tm) reagent grade, 98%
Q3604488
5,5'-dithio-bis-(2-nitrobenzoic acid) - cas 69-78-3
STL191445
ellman inverted exclamation mark s reagentellman inverted exclamation mark s reagent
H10309
5-[(3-carboxy-4-nitrophenyl)dithio]-2-nitrobenzoic acid
ellmans reagenz
EN300-153235
5,5'-dithobis(2-nitrobenzoic acid)
Z1723556601
5,5 inverted exclamation mark -dithiobis(2-nitrobenzoic acid)
SY014933
AC-37019

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" The BALB-DTNB method has a higher sensitivity than the conventional serum lipase assay methods, and proved useful for analyzing the properties of serum lipases in combination with gel-filtration on a Sephacryl S 200 column and isoelectrofocusing in an Ampholine column."( Properties of serum lipase in patients with various pancreatic diseases. Analysis by a new serum lipase assay method (the BALB-DTNB method) in combination with gel-filtration and iso-electrofocusing techniques.
Kitamura, T; Kurooka, S, 1978
)
0.26

Dosage Studied

ExcerptRelevanceReference
" In addition, our preparation did not demonstrate the long-lasting responses to bromoaTT-induced depression of the nicotinic responses was studied on the dose-response curves; the mode of receptor inhibition was rather complexed, being neither type of competitive nor non-competitive."( Effects of disulfide bond reduction on the excitatory and inhibitory postsynaptic responses of Aplysia ganglion cells.
Sato, M; Sato, T; Sawada, M, 1976
)
0.26
" DTT treatment also markedly shifted the dose-response curve of NMDA to the left."( Redox modulation of N-methyl-D-aspartate-stimulated neurotransmitter release from rat brain slices.
Blair, R; Woodward, JJ, 1991
)
0.28
" Conversely, following potentiation of the response to histamine with DTT, exposure of the tissue to desensitizing concentrations of histamine resulted in a dextral shift of the dose-response curve (dose ratio = 39."( Selective enhancement of histamine H1-receptor responses in guinea-pig ileal smooth muscle by 1,4-dithiothreitol.
Donaldson, J; Hill, SJ, 1986
)
0.27
" Treatment of strips with PCMB and DTNB did not alter the dose-response curves for GTN."( Investigations into the role of sulfhydryl groups in the mechanism of action of the nitrates.
Armstrong, PW; Marks, GS; Moffat, JA, 1982
)
0.26
"Chemical modification of membrane-bound Torpedo californica acetylcholine receptor by the disulfide reducing agent dithiothreitol has two major effects on receptor function: (1) it shifts the dose-response curve for agonist-induced increases in 22Na+ permeability to 10-fold higher concentrations, and (2) it decreases the binding affinity of the receptor for the same agonist about 6-fold."( Effects of thio-group modifications on the ion permeability control and ligand binding properties of Torpedo californica acetylcholine receptor.
Lukas, RJ; McNamee, MG; Walker, JW, 1981
)
0.26
" The dose-response was similar for thioredoxin reductase and glutathione peroxidase, but the recovery of glutathione peroxidase activity upon selenium supplementation was faster than with thioredoxin reductase."( Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase.
Flohé, L; Marcocci, L; Packer, L, 1997
)
0.3
" The noncompetitive antagonist MK-801 and a glycine-site blocker were equally neuroprotective in both normal and reduced conditions, but there was a significant rightward shift in the dose-response curves of the competitive antagonists APV and CPP and the uncompetitive antagonist memantine."( Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
Eshak, M; Iannotti, F; Pringle, AK; Self, J, 2000
)
0.31
" At the same time, a number of nonmetallic ligands moderately accelerate the reaction of MT with Nbs2 and hyperbolic dose-response curves were obtained."( The effects of physiologically important nonmetallic ligands in the reactivity of metallothionein towards 5,5'-dithiobis(2-nitrobenzoic acid). A new method for the determination of ligand interactions with metallothionein.
Kangur, L; Palumaa, P, 2001
)
0.31
"A simple and sensitive spectrophotometeric method has been developed for the determination of captopril in its dosage form."( Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation.
Amini, M; Ebrahimi, P; Hassani, N; Hosseinimehr, SJ; Mirzabeigi, P,
)
0.13
" Redox modulation of GABArho(1) receptors was strongly dependent on the GABA concentration; dose-response curves for GABA were shifted to the left in the presence of reducing agents, whereas oxidizing agents produced the opposite effect, without changes in the maximal response to GABA and in the Hill coefficient."( Redox modulation of homomeric rho1 GABA receptors.
Calero, CI; Calvo, DJ, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
indicatorAnything used in a scientific experiment to indicate the presence of a substance or quality, change in a body, etc.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
nitrobenzoic acidAny member of the class of benzoic acids with at least one nitro substituent attached to the benzene ring.
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Thymidylate kinaseHomo sapiens (human)IC50 (µMol)1.53001.53001.53001.5300AID649640
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ribonuclease TEscherichia coli K-12INH100.000010.000010.000010.0000AID1316273
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
dTDP biosynthetic processThymidylate kinaseHomo sapiens (human)
dTTP biosynthetic processThymidylate kinaseHomo sapiens (human)
response to estrogenThymidylate kinaseHomo sapiens (human)
myoblast differentiationThymidylate kinaseHomo sapiens (human)
thymidine biosynthetic processThymidylate kinaseHomo sapiens (human)
response to cadmium ionThymidylate kinaseHomo sapiens (human)
nucleoside monophosphate phosphorylationThymidylate kinaseHomo sapiens (human)
cellular response to growth factor stimulusThymidylate kinaseHomo sapiens (human)
dUDP biosynthetic processThymidylate kinaseHomo sapiens (human)
RNA processingRibonuclease TEscherichia coli K-12
DNA damage responseRibonuclease TEscherichia coli K-12
tRNA processingRibonuclease TEscherichia coli K-12
rRNA 3'-end processingRibonuclease TEscherichia coli K-12
cellular response to UVRibonuclease TEscherichia coli K-12
tRNA 3'-end processingRibonuclease TEscherichia coli K-12
regulatory ncRNA 3'-end processingRibonuclease TEscherichia coli K-12
DNA replication proofreadingRibonuclease TEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
thymidylate kinase activityThymidylate kinaseHomo sapiens (human)
ATP bindingThymidylate kinaseHomo sapiens (human)
nucleoside diphosphate kinase activityThymidylate kinaseHomo sapiens (human)
3'-5'-RNA exonuclease activityRibonuclease TEscherichia coli K-12
magnesium ion bindingRibonuclease TEscherichia coli K-12
nucleic acid bindingRibonuclease TEscherichia coli K-12
exonuclease activityRibonuclease TEscherichia coli K-12
RNA nuclease activityRibonuclease TEscherichia coli K-12
protein bindingRibonuclease TEscherichia coli K-12
single-stranded DNA 3'-5' DNA exonuclease activityRibonuclease TEscherichia coli K-12
3'-5' exonuclease activityRibonuclease TEscherichia coli K-12
RNA exonuclease activity, producing 5'-phosphomonoestersRibonuclease TEscherichia coli K-12
identical protein bindingRibonuclease TEscherichia coli K-12
protein homodimerization activityRibonuclease TEscherichia coli K-12
metal ion bindingRibonuclease TEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
mitochondrial matrixThymidylate kinaseHomo sapiens (human)
cytosolThymidylate kinaseHomo sapiens (human)
mitochondrionThymidylate kinaseHomo sapiens (human)
nucleusThymidylate kinaseHomo sapiens (human)
cytoplasmThymidylate kinaseHomo sapiens (human)
cytosolRibonuclease TEscherichia coli K-12
cytosolRibonuclease TEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1316273Inhibition of N-terminal His-tagged recombinant Escherichia coli K-12 RNase T exonuclease activity expressed in Escherichia coli BL21-CodonPlus(DE3)-RIPL preincubated for 10 mins followed by [gamma-32P]ATP labelled 11-nucleotide ssDNA substrate addition f2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID649640Inhibition of human thymidylate kinase using dTMP as substrate after 30 mins by fluorescence analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation.
AID1524436Substrate activity at recombinant Haemophilus influenzae Chloramphenicol nitroreductase expressed in Escherichia coli assessed as initial rate of reaction at 150 uM measured at 30 sec interval for 5 mins in presence of NADPH at pH 8 under 37 degC by UV-vi2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Investigating the promiscuity of the chloramphenicol nitroreductase from Haemophilus influenzae towards the reduction of 4-nitrobenzene derivatives.
AID513575Induction of S-nitrosylation of TRPC5 in HEK cells assessed as increase in Ca2+ level from extracellular space at 50 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID1316276Inhibition of 5'-[gamma-32P]ATP-labelled 11-nucleotide ssDNA binding to recombinant Escherichia coli K-12 N-terminal His-tagged RNase T expressed in Escherichia coli BL21-CodonPlus(DE3)-RIPL at 1 mM preincubated for 10 mins followed by substrate addition 2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID298091Inhibition of wild type HIV YU2 gp120 to CD4 binding2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
AID1316277Inhibition of Lassa virus N-terminal His-tagged NP exonuclease domain (342 to 569 residues) expressed in Escherichia coli Tuner (DE3) using FAM-labeled 20-nucleotide ssRNA preincubated for 10 mins followed by substrate addition measured after 60 mins by P2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID1316272Inhibition of GST-tagged Caenorhabditis elegans CRN-4 exonuclease activity expressed in Escherichia coli BL21 (DE3) pLysS preincubated for 10 mins followed by [gamma-32P]ATP labelled 11-nucleotide ssRNA substrate addition for 30 mins by PAGE based autorad2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID1316278Inhibition of Lassa virus N-terminal His-tagged NP exonuclease domain (342 to 569 residues) expressed in Escherichia coli Tuner (DE3) using 3'-overhang 4-nucleotide stem-loop RNA preincubated for 10 mins followed by substrate addition measured after 60 mi2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID1316274Inhibition of 5'-[gamma-32P]ATP-labelled 11-nucleotide ssRNA binding to Caenorhabditis elegans GST-tagged CRN-4 expressed in Escherichia coli BL21 (DE3) pLysS at 1 mM preincubated for 10 mins followed by substrate addition measured after 20 mins by TBE ge2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Identification of Inhibitors for the DEDDh Family of Exonucleases and a Unique Inhibition Mechanism by Crystal Structure Analysis of CRN-4 Bound with 2-Morpholin-4-ylethanesulfonate (MES).
AID1686310Binding affinity to GST-tagged human TMPK expressed in Escherichia coli BL21 assessed as formation of disulfide bonds with Cys residues incubated for 30 mins at 25 degC in presence of trypsin by LC-MS/MS analysis2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
Chemical Inhibition of Human Thymidylate Kinase and Structural Insights into the Phosphate Binding Loop and Ligand-Induced Degradation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,825)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990875 (47.95)18.7374
1990's504 (27.62)18.2507
2000's285 (15.62)29.6817
2010's131 (7.18)24.3611
2020's30 (1.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.60 (24.57)
Research Supply Index7.54 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (0.16%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,880 (99.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]